Pancreatic Cancer Research

ResearcherNanjing Medical UniversityNo recent work listed

Wei Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3263-8346; OpenAlex author ID A5101881514. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Inhibition of Dishevelled-2 suppresses the biological behavior of pancreatic cancer by downregulating Wnt/β-catenin signaling. Co-author DOI 10.3892/ol.2021.13030↗
  2. Oncogenic Activities Of UBE2S Mediated By VHL/HIF-1α/STAT3 Signal Via The Ubiquitin-Proteasome System In PDAC. Last author DOI 10.2147/ott.s228522↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mingxu Li · 1 shared paper, 2021 · strength 0.15
  2. Zhong Wang · 1 shared paper, 2021 · strength 0.15
  3. Yiyi Liang · 1 shared paper, 2019 · strength 0.11
  4. Lei Wang · 1 shared paper, 2019 · strength 0.11
  5. Pengping Li · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.